about
Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer typesClassic Kaposi's sarcoma in Italy, 1985-1998Pattern of cancer risk in persons with AIDS in Italy in the HAART era.Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects.Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy.Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa).Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997-2001)Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size.Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.MIB-1 proliferative activity in invasive breast cancer measured by image analysis.Cancer incidence in Italian contaminated sites.Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods.Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study.Establishment of keratinocyte colonies from small-sized cervical intraepithelial neoplasia specimens.Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of Ferrara, northern Italy.The burden of HPV-related diseases in Italy, 2001-12.Screening for colorectal cancer in Italy: 2011-2012 survey.Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma.Changes in cervical cancer incidence following the introduction of organized screening in Italy.Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis.In situ breast cancer: incidence trend and organised screening programmes in Italy.Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation.Completeness and timeliness: Cancer registries could/should improve their performance.Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy.Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis.Breast screening: axillary lymph node status of interval cancers by interval year.Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy.Coding criteria of bladder cancer: effects on estimating survival.Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.Modulation of biomarkers in minimal breast carcinoma: a model for human breast carcinoma progression.The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al.Non-Hodgkin lymphoma among young adults with and without AIDS in Italy.Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.Cancer trends in Italy: figures from the cancer registries (1986-1997).Upper gastrointestinal tract cancers: oesophagus, stomach, liver, gallbladder and biliary ducts, pancreas.Population-based incidence and mortality cancer trends (1986-1997) from the network of Italian cancer registries.
P50
Q34395344-C204419E-BB34-4A5E-8B3E-FB0D19FC4661Q34552954-44CCCF49-DA9B-4286-9D88-C800176DF0A9Q34604639-9F009F32-89AF-435A-9331-441575C243ACQ34624429-CF8FCE63-4271-474C-9AB3-8313F09D7FCDQ34890475-0593E1A9-D98D-4D21-92D0-077D7B351474Q35633665-E0BC3B51-9D06-495B-924D-273D693D9797Q35787535-4B313586-7648-4CEC-8414-170BDD1A46F2Q36611927-7C57BAD9-8005-45C1-B454-FFBD69D82817Q36615721-DD1F8BA5-C6ED-4F32-852E-1DEFA43EC038Q36858064-8AEBEE13-142B-41A8-A895-B120E0820E5BQ37225460-7FD8962B-133C-426C-8E5C-EAE1D68F0FACQ38420064-B1E297E5-55BA-49B1-BF29-BCBC49D8E59CQ38426380-8ED87757-1384-412F-A45D-65A573637BBFQ38438959-8049F9AF-187F-4E81-BB3D-B825BE777A6CQ39379072-ADE8BE68-FCEC-4642-B1EB-82249825851FQ39384836-5C45E86D-D5B2-4F98-81B9-B01FEBFD6B9CQ40127962-CC230397-0E1B-495D-BF65-630E92AEE7EBQ40277632-04770EE4-F7D7-4F11-A32E-B6CD36D55BB2Q40502655-6328FD84-9573-403F-9C9D-65CBCEAF57B2Q40549413-DAC8E2C5-90C7-47E0-832D-E774260C1CA3Q41146852-13F62363-35C0-45FE-8560-CB0D31A4B241Q41978080-F05EA0A0-3CCD-4EEA-B66F-635DC5E58D99Q43467861-CF8713F5-31E4-4FD9-BCB4-422512F53C3CQ43561645-E4EB3431-B604-43CD-A87B-43FAB968B7E4Q43604110-FD967EFE-CD34-4857-BC19-CE71656774A4Q43619319-5B535862-3D48-44CE-8EF6-BFFB4D272D75Q43790629-C943FF87-0C85-400A-8A35-085E7A2DD7D5Q43791052-376BAEEF-AE96-44F3-956C-2DC331833F32Q43822277-2386515F-1933-4288-ACB1-61D227155767Q43935919-23FAE2D1-B931-4DA7-A0B6-1D4DC1D579D4Q44010790-B41AF25B-A293-44A6-B40A-4EAD9C71AD6CQ44675865-FEE61A42-6DA7-432D-B24D-CEA4715E166BQ44929198-6F52F1BF-00E4-4A05-B64E-4A5640CEC560Q45595175-FA3B8B59-53F8-4789-BA59-37B27A56A323Q46983029-FA895858-0016-4E45-ACC1-20D48F4565ABQ48825292-BBA34C65-A9A0-4979-93A6-B2ADDD855766Q49247245-B33E041A-1510-4BCA-A210-3D57BF669E3FQ50747013-6BE20C9E-D422-45ED-A75F-EDB83537A6D6Q50747020-1F3AC7FC-263E-49D4-9242-C3FC45D3E99DQ50752160-BE100CF2-07AA-4E63-9FF0-EF087A20EC3F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefano Ferretti
@ast
Stefano Ferretti
@en
Stefano Ferretti
@es
Stefano Ferretti
@nl
Stefano Ferretti
@sl
type
label
Stefano Ferretti
@ast
Stefano Ferretti
@en
Stefano Ferretti
@es
Stefano Ferretti
@nl
Stefano Ferretti
@sl
prefLabel
Stefano Ferretti
@ast
Stefano Ferretti
@en
Stefano Ferretti
@es
Stefano Ferretti
@nl
Stefano Ferretti
@sl
P1053
K-8636-2015
P106
P1153
35313768800
P21
P31
P3829
P496
0000-0001-5241-2101